Clinical Trials in Denver

Showing 15141-15160 of 18,161 trials

Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT00125385

This study is designed to investigate whether GC1008, an antibody that neutralizes TGFb, is safe in treating patients with idiopathic pulmonary fibrosis. The highest dose without excessive side effects will be identified. Tests will determine how long GC1008 is in the body and how it is excreted.

Idiopathic Pulmonary Fibrosis

Genzyme, a Sanofi Company25 participantsStarted Jul 2005

Denver, Colorado, United States • Chicago, Illinois, United States • Ann Arbor, Michigan, United States +5 more locations

COMPLETEDPhase 3< 1 mile

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

NCT00295633

The purpose of this clinical research study is to learn whether Saxagliptin added to thiazolidinedione (TZD) therapy is more effective than TZD alone as a treatment for Type 2 diabetic subjects who are not sufficiently controlled with TZD alone

Diabetes Mellitus, Type 2

AstraZeneca565 participantsStarted Mar 2006

Haleyville, Alabama, United States • Mobile, Alabama, United States • Ozark, Alabama, United States +130 more locations

Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

Find Trials by Condition in Denver

Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication

Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine

CHARITE™ vs. ALIF 5-Year Follow-up

Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure

A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome

Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment

Effect on Weight Loss of Exenatide Versus Placebo

Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer

Grass Observational Study

Improving Antipsychotic Adherence Among Patients With Serious Mental Illness

Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With Diabetes

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

Group Visits to Improve Hypertension Management

Progressive Intervention Program for Tinnitus Management

Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I